Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Hydrochloric acid dapoxetine technology impurities, preparation and use thereof

A technology of dapoxetine hydrochloride and hydrochloride, applied in the field of drug synthesis, can solve the problems such as no process impurity report yet

Inactive Publication Date: 2018-10-02
扬子江药业集团江苏紫龙药业有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Currently, no process impurities have been reported in this production route

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hydrochloric acid dapoxetine technology impurities, preparation and use thereof
  • Hydrochloric acid dapoxetine technology impurities, preparation and use thereof
  • Hydrochloric acid dapoxetine technology impurities, preparation and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1: Synthesis of 3,3'-oxybis(1-phenyl-1-propanone) (compound 2)

[0031] Add 100mL toluene and 20mL water into a 500mL three-necked flask, start stirring, add 20.00g SM1 (3-chloropropiophenone), 2.00g p-toluenesulfonic acid in sequence, raise the temperature to 90°C, keep stirring for 24 hours, and take samples for LCMS Detection, product generation (m / z=283[M+H] + ). Separate the liquid, collect the organic phase, control the temperature at 30-40°C, vacuum degree: -0.08 MPa, distill under reduced pressure, and distill off the solvent until no distillate is distilled to obtain 18.62 g of a yellow oily substance. The obtained crude product was separated and purified by column chromatography, the eluent ratio was: methanol: dichloromethane = 1:50, a total of 1600 mL of eluent was collected, the temperature was controlled at 30-40 ° C, vacuum degree: -0.08 MPa, and vacuum distillation , the solvent was distilled off until no distillate was distilled to obtain 2.52...

Embodiment 2

[0032] Example 2: Synthesis of 3,3'-oxybis(1-phenyl-1-propanol) (compound 3)

[0033] Add 50mL of methyl tert-butyl ether into a 250mL three-necked flask, start stirring, add 2.00g of 3,3'-oxybis(1-phenyl-1-propanone) (compound 2), cool down to 0-10°C, Slowly add 1.02 g of sodium borohydride in batches, and react overnight at room temperature after the addition is complete. A sample was taken for TLC detection (n-heptane: ethyl acetate = 8:1), and the raw material disappeared. Control the temperature at 10-20°C, slowly add 50mL of hydrochloric acid solution (1mol / L), separate the liquid, collect the organic phase, control the temperature at 30-40°C, vacuum: -0.08MPa, distill under reduced pressure, distill off the solvent until there is no distillate. 1.65 g of transparent oil was obtained, yield: 81.34%. That is, 3,3'-oxybis(1-phenyl-1-propanol) was obtained.

Embodiment 3

[0034] Example 3: Synthesis of 3,3'-oxybis(N,N-dimethyl-1-amphetamine) hydrochloride (impurity A)

[0035] Add 20ml of methyl tert-butyl ether to a 100mL three-necked flask, start stirring, and then add 1.16g of 3,3'-oxybis(1-phenyl-1-propanol) (compound 3), 0.98g of triethylamine , under nitrogen protection, lower the temperature to 10-20°C, start to add 1.00g of methanesulfonyl chloride dropwise, after dropping, continue to stir for 1-2 hours, take a sample for TLC detection (n-heptane: ethyl acetate = 3:2), the raw material disappear. Add 60 mL of dimethylamine tetrahydrofuran solution (2 mol / L) to the system, raise the temperature to 30°C, and stir overnight; take a sample for TLC detection (n-heptane: ethyl acetate = 4:1) and the raw material disappears. Add 60ml of purified water, separate the liquid, collect the organic phase, distill under reduced pressure, distill off the solvent until no fraction is distilled off to obtain an oily crude product, which will be purifi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the field of drug synthesis, and relates to impurities in a raw material medicine production process and a preparation method thereof, in particular to a hydrochloric acid dapoxetine: the technology impurities of (+)-(S)-N,N-dimethyl-(alpha)-[2-(1-naphthyloxy) ethyl] benzylamine hydrochloride and the preparation method thereof. The impurities are selected from a compound A(3,3'-oxybis(N,N-dimethyl-1-amphetamine) hydrochloride), a compound D (N,N-dimethyl-3-(1-naphthyloxy)-N-(3-(1-naphthyloxy)-1-phenylpropyl)-1-phenylpropylammonium chloride).

Description

technical field [0001] The invention belongs to the field of drug synthesis, and relates to process impurities in the production process of raw materials and their preparation, in particular to dapoxetine hydrochloride process impurities and a preparation method thereof. Background technique [0002] Premature ejaculation is a common male disorder, estimated to affect up to 30-40% of men. Premature ejaculation may involve prostatitis and neurological diseases. In principle, some selective serotonin reuptake inhibitors can be used for treatment, such as fluoxetine, paroxetine, sertraline, etc. However, the above drugs have relatively large side effects and are not suitable for the treatment of premature ejaculation. In December 2008, dapoxetine hydrochloride was approved in seven European countries successively. Finland and Sweden were the first two countries to be approved, followed by Austria, Spain, Germany, Italy and Portugal. In early 2009, Johnson & Johnson announced ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C217/48G01N30/02G01N30/06
CPCG01N30/02G01N30/06C07C217/48
Inventor 陈岩张帆何学敏薛磊
Owner 扬子江药业集团江苏紫龙药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com